Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 4 1

Status

Completed 3Withdrawn 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

CNS 1

Conditions

Insulin Resistance 2Hyperglycemia 2Intracranial Aneurysm 1Hypoglycemia 1Hyperphagia 1Brain Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Insulin × Clear all
NCT03904199 2023-01-20

Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Completed
9 enrolled

Hyperglycemia

NCT00993057 2019-12-13

Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia

Northwestern University

Phase EARLY_PHASE1 Completed
120 enrolled
CNS

Brain Neoplasms, Intracranial Aneurysm, Hypoglycemia, Insulin Resistance

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed
61 enrolled

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡